Microplastics in Cosmetics: What Testing Labs Detect and Where Regulations Are Heading

Microplastics in cosmetics didn’t become a regulatory issue overnight. The US took its first meaningful swing at the problem in 2015 with the Microbead-Free Waters Act — banning solid plastic particles in rinse-off products like facial scrubs and toothpaste. At the time, it felt like a decisive response. But the law was deliberately narrow: microbeads, rinse-off products, done. A decade later, synthetic polymer ingredients appear in thousands of leave-on formulas — foundations, pressed powders, sunscreens, serums — and remain almost entirely unregulated at the federal level.

The EU moved considerably further. In October 2023, a REACH restriction on intentionally added microplastics entered into force across the European market, covering a far broader set of polymer types and product categories than any US law has touched. Brands exporting to Europe are already operating on a countdown clock. And given that California cosmetic regulation has historically foreshadowed federal action by years, the window before US requirements tighten is shorter than most brands realize.

For cosmetics companies building out their testing programs right now, this is the moment to understand what’s actually in your formulas — before regulators require you to find out the hard way.

What Actually Counts as a Microplastic in a Cosmetic Formula

The 5 mm threshold — any solid synthetic polymer particle smaller than that qualifies as a microplastic — sounds simple enough. But formulators know it gets complicated quickly. Glitter particles are the obvious case. So are polyethylene spheres used as optical diffusers, nylon-12 powder for skin texture and slip, and polyurethane foam used in some powder formulations. Less obvious are acrylates cross-polymers functioning as film-formers or viscosity modifiers, low-molecular-weight synthetic waxes derived from polyethylene, and polymer fibers that appear as processing contaminants rather than intentional ingredients.

The EU REACH restriction takes a deliberately broad view. It covers particles, films, and fibers of synthetic polymers — including polymers that may degrade under controlled laboratory conditions but don’t break down at meaningful rates in aquatic environments. That distinction matters. A polymer that biodegrades in a controlled lab setting in 90 days may persist in a riverine or marine system for years, and that’s precisely what the ECHA restriction targets.

Common INCI entries to flag during a formulation audit include:

• Polyethylene — optical diffusers, exfoliants
• Nylon-12, Nylon-6 — powder texturizers and mattifiers
• Acrylates Copolymer / Acrylates/C10-30 Alkyl Acrylate Crosspolymer — rheology modifiers, film formers
• Polyurethane-35 and related polymers — film formers, conditioning agents
• PET- or polyester-based glitters — color cosmetics, body products
• Synthetic Fluorphlogopite — mica substitute in powder formulas (check binder composition)

Not every ingredient on this list is automatically restricted under the EU rule — exemptions exist for polymers used in controlled-release applications and for certain natural polymer derivatives. But the burden is increasingly on brands to demonstrate that their ingredients qualify for an exemption, not on regulators to prove they don’t.

How Cosmetic Testing Labs Actually Detect Microplastics

Detecting microplastics in a cosmetic matrix is analytically demanding. The challenge isn’t just identifying the polymer type — it’s separating target particles from a formulation that may contain dozens of organic compounds, emulsifiers, pigments, and thickeners that interfere with analysis. Method selection and sample preparation matter as much as the instrument itself.

ATR-FTIR (Attenuated Total Reflectance Fourier Transform Infrared Spectroscopy) is typically the first-pass method. Each synthetic polymer absorbs infrared light at characteristic wavelengths, producing a spectral fingerprint that can be matched against reference libraries. ATR-FTIR works reliably for particles above roughly 500 µm, but resolution degrades significantly below that threshold.

Micro-FTIR (µ-FTIR) couples the FTIR spectrometer with an optical microscope, enabling particle-level imaging and identification down to approximately 10–20 µm. For complex emulsion or powder formulas, µ-FTIR is the method of choice when particle counts, size distribution data, and polymer identification are all required from a single analysis run. Samples typically require a digestion step — enzymatic treatment, Fenton oxidation, or hydrogen peroxide processing — to remove the organic matrix before particles can be imaged cleanly.

Raman Spectroscopy complements FTIR well and handles cases where FTIR struggles. Dark-colored particles — black pigments, certain iron oxides — absorb infrared light and can obscure the polymer signal. µ-Raman sidesteps this limitation and can resolve particles down to approximately 1 µm. The trade-off is sensitivity to autofluorescence from some organic colorants, which can mask the Raman signal entirely.

Pyrolysis-GC/MS takes a fundamentally different approach: the sample is thermally decomposed under controlled conditions, and breakdown products are identified by gas chromatography-mass spectrometry. It doesn’t produce particle counts or morphological data, but it delivers reliable mass concentration results — useful when you need to report polymer content against a specific regulatory limit rather than simply confirm what polymer types are present.

Sample preparation is where most microplastic analyses go wrong. In our experience working with cosmetic brands, formulations submitted without adequate pre-treatment consistently produce false negatives — particles masked by the surrounding matrix that instruments never see. When you’re evaluating a cosmetic testing laboratory’s capabilities, ask specifically about their sample preparation protocol and digestion approach, not just which instrument platform they operate. That single question reveals more about methodological rigor than any instrument specification sheet will.

Where US Regulations Stand — and What’s Clearly Coming

Federally, the US has not moved beyond the Microbead-Free Waters Act. FDA’s current framework doesn’t restrict microplastics in leave-on formulas, and recent FDA guidance documents haven’t introduced new requirements in this area. That regulatory gap spans the full range of leave-on products: foundations, lipsticks, serums, sunscreens, hair treatments.

But the pressure points are already active and building.

EU export requirements are the most immediate concern. Brands with European distribution must comply with REACH Restriction 2023/2055. Phase-out timelines are product-category specific: rinse-off cosmetics face a deadline of October 2027 — approximately 18 months from now — and leave-on cosmetics follow in October 2029. Glitter-containing products have extended timelines, but brands in those categories still need documented ingredient assessments today to demonstrate compliance planning to EU distributors and retailers.

Retailer requirements are already functioning as de facto regulations for many mid-size brands. Several major US chains now require suppliers to disclose microplastic-containing ingredients, provide validated analytical test data, and in some cases commit to reformulation timelines. A brand that can produce a report from an accredited cosmetic testing laboratory moves through that review considerably faster than one offering a self-attestation based on an INCI review alone.

California’s regulatory trajectory is worth tracking carefully. The state’s Safe Cosmetics Program already requires disclosure of ingredients associated with cancer or reproductive harm. The scientific literature on microplastic particle inhalation, dermal penetration, and systemic distribution is accumulating fast enough that an expanded reporting requirement within the California framework is plausible within the next few regulatory cycles. California-based manufacturers would be affected first — and given Qalitex’s work with Southern California brands, we’re watching this closely.

Litigation exposure is real. Class-action suits around “clean” or “natural” labeling on products containing synthetic polymer ingredients have already been filed against cosmetic brands in US courts. Having analytical test data on file doesn’t prevent litigation, but it substantially changes the defense posture and the speed of the response.

What a Baseline Testing Program Looks Like in Practice

The practical starting point is an INCI audit. Review every ingredient against a current list of polymer-based ingredients — this identifies obvious candidates quickly and gives you a prioritized list of products that need analytical follow-up first.

From there, a µ-FTIR analysis on the finished formulation provides particle identification, size distribution, and particle count data in a single run. Across a product line, a reasonable approach is to analyze one representative formula from each platform — a water-in-oil emulsion, an anhydrous formula, a loose powder — and expand based on what those initial results show. Products with multiple synthetic polymer entries in the INCI naturally move to the front of the queue.

For EU compliance documentation, the analytical report needs to specify the detection method, instrument calibration status, sample preparation protocol, detection limits, and quantitative results. A report that simply states “no microplastics detected” without a stated detection limit is not useful for ECHA compliance purposes and will typically be rejected during a retailer sustainability audit. ISO 17025 accreditation means the method has been validated, measurement uncertainty is characterized, and the report meets international standards for technical documentation.

Brands already selling into the EU or planning a European launch in 2026 or 2027 should have this work underway now. Analytical testing, reformulation evaluation, supplier discussions, and updated compliance documentation don’t compress easily into a 60-day sprint.

Start with one product. Understand what’s in it. The data from that first analysis almost always informs a broader reformulation strategy more efficiently than any internal ingredient review can on its own — and the clock on EU compliance is already running.

---

Written by Nour Abochama, Vice President of Operations, Qalitex Laboratories. Learn more about our team

Talk to our team about your testing needs. Contact us

Related from our network

• FDA Regulatory Strategy for Cosmetics and MoCRA Compliance — Aurora TIC helps US cosmetic brands navigate FDA registration, safety substantiation, and pre-market documentation requirements.
• Raw Material Polymer Screening and Supplier Qualification Testing — Ayah Labs provides ingredient-level testing and COA verification for cosmetic raw material suppliers worldwide.